Literature DB >> 1286710

Retinopathy of prematurity: a prospective study. Review at six months.

D Laws1, D E Shaw, J Robinson, H S Jones, Y K Ng, A R Fielder.   

Abstract

A cohort of infants of birthweight < or = 1700 g studied prospectively for retinopathy of prematurity (ROP) has been reviewed at 6 months corrected age and the findings related to the neonatal data. The overall incidence of strabismus was 6.4% (30/468), rising from 3.1% (7/229) without ROP to 29.2% (7/24) with stage 3. Strabismus and fusional ability were significantly related to presence and severity of ROP, and abnormal neonatal cranial ultrasound findings. Binocular visual acuity was measured in 340 infants between 20 and 40 weeks corrected age. Eight were subnormal, all due to neurological problems. For the remainder, despite falling within the normal range, there was a significant trend (p < 0.001) for lower acuities with increasing ROP severity. Cycloplegic refraction on 387 infants revealed, with increasing ROP severity: 1, a significant trend towards myopia; 2, increased magnitude of astigmatism; 3, alteration of the astigmatic axis; 4, increased incidence of anisometropia. For the first three categories there was an insignificant trend between no ROP and stage 2, reaching significance only between stage 2 and 3. The predominant axis of astigmatism in infants without ROP was between 60 degrees and 120 degrees, but with ROP there was a significant trend away from this direction.

Entities:  

Mesh:

Year:  1992        PMID: 1286710     DOI: 10.1038/eye.1992.101

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Risk factors for strabismus in children born before 32 weeks' gestation.

Authors:  P M Pennefather; M P Clarke; N P Strong; D G Cottrell; J Dutton; W Tin
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study.

Authors:  F Laws; D Laws; D Clark
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness.

Authors:  M Y Choi; I K Park; Y S Yu
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

4.  Change of refractive state and eye size in children of birth weight less than 1701 g.

Authors:  A R O'Connor; T J Stephenson; A Johnson; M J Tobin; S Ratib; A R Fielder
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 5.  The neurovascular retina in retinopathy of prematurity.

Authors:  Anne B Fulton; Ronald M Hansen; Anne Moskowitz; James D Akula
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

6.  Ophthalmological long-term follow up of preterm infants: a population based, prospective study of the refraction and its development.

Authors:  M Holmström; M el Azazi; U Kugelberg
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

7.  The inner retinal structures of the eyes of children with a history of retinopathy of prematurity.

Authors:  Y-S Lee; S H L Chang; S-C Wu; L-C See; S-H Chang; M-L Yang; W-C Wu
Journal:  Eye (Lond)       Date:  2017-08-04       Impact factor: 3.775

8.  Ophthalmological follow up of preterm infants: a population based, prospective study of visual acuity and strabismus.

Authors:  G Holmström; M el Azazi; U Kugelberg
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

9.  Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis).

Authors:  Rand Spencer
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.

Authors:  Bradley V Davitt; Velma Dobson; Graham E Quinn; Robert J Hardy; Betty Tung; William V Good
Journal:  Ophthalmology       Date:  2008-12-16       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.